Ikarian Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-160,200
| Closed | -$1.77M | – | 127 |
|
|
2023
Q2 | $1.77M | Buy |
160,200
+75,000
| +88% | +$830K | 0.28% | 34 |
|
|
2023
Q1 | $1.14M | Hold |
85,200
| – | – | 0.26% | 48 |
|
|
2022
Q4 | $1.05M | Hold |
85,200
| – | – | 0.25% | 36 |
|
|
2022
Q3 | $1.19M | Sell |
85,200
-19,800
| -19% | -$276K | 0.24% | 34 |
|
|
2022
Q2 | $1.45M | Buy |
105,000
+69,851
| +199% | +$964K | 0.26% | 37 |
|
|
2022
Q1 | $572K | Buy |
35,149
+584
| +2% | +$9.5K | 0.08% | 91 |
|
|
2021
Q4 | $562K | Hold |
34,565
| – | – | 0.08% | 92 |
|
|
2021
Q3 | $513K | Sell |
34,565
-435
| -1% | -$6.46K | 0.04% | 123 |
|
|
2021
Q2 | $700K | Hold |
35,000
| – | – | 0.06% | 123 |
|
|
2021
Q1 | $808K | Buy |
+35,000
| New | +$808K | 0.03% | 133 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 159 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 140 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 122 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 83 |
|